Stake­hold­ers weigh in on po­ten­tial re­forms to FDA ad­vi­so­ry com­mit­tee process

The FDA on Thurs­day heard feed­back from a slew of stake­hold­ers on po­ten­tial up­com­ing changes to the ad­vi­so­ry com­mit­tee process — and the re­views were mixed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.